Special Issue "Cardiometabolic Challenges-Present and Future"
A special issue of Metabolites (ISSN 2218-1989).
Deadline for manuscript submissions: 30 November 2020.
1. Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties (PROMISE), University of Palermo, 90127 Palermo, Italy
2. Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, University of South Carolina, Columbia, 29208 SC, USA
Interests: diabetes; cardiovascular prevention; lipids and lipoproteins; metabolic syndrome
Interests: diabetes; nutrition; metabolic diseases; chronic kidney disease
Cardiovascular diseases represent the first cause of morbidity and mortality in most industrialised countries, and metabolic alterations are so strictly linked that is common to talk about the two as a whole, referring to them as cardiometabolic. Due to increasing sedentary habits and profound life habit changes, the cardiometabolic risk is an emerging problem in the entire planet, and it is crucial to identify the right targets of prevention and therapy. This Special Issue is dedicated to reviewing the current practical aspects of insulin resistance, and type-2 diabetes, atherogenic dyslipidemia, PCSK9 inhibition, hypertension, overweight and obesity, uric acid alteration, obstructive sleep apnea, chronic kidney disease, polycystic ovary syndrome ,and non-alcoholic fatty liver disease and will also highlight the most critical targets of prevention and therapy for an effective reduction of cardiometabolic risk. The triumvirate of metabolic syndrome, chronic kidney diseases, and coronary heart disease has as its mainstay oxidative stress and chronic inflammation. In the light of the determinations of new markers involved in this triad, as well as the new therapies focusing on cardio-renometabolic components, this edition aims to bring a modern approach to all innovations in this field.
Prof. Dr. Manfredi Rizzo
Prof. Dr. Anca Pantea Stoian
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Metabolites is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- cardiometabolic syndrome
- cardiometabolic risk
- cardio-renometabolic markers
- insulin resistance
- type-2 diabetes
- chronic kidney disease